Rapid Resolution of Life-Threatening Hypertriglyceridemia after Evinacumab Administration in a Pediatric HSCT Recipient: A Case Report

• Główni autorzy: Alice Fachin (Autor), Chiara De Carlo (Autor), Alessandra Maestro (Autor), Davide Zanon (Autor), Egidio Barbi (Autor), Natalia Maximova (Autor)
• Format: Książka
• Wydane: MDPI AG, 2023-07-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

Evinacumab, a human monoclonal antibody against angiopoietin-like protein 3 (ANGPTL3), has recently been approved by the U.S. Food and Drug Administration as an add-on therapy for homozygous familial hypercholesterolemia (HoFH) in patients of 12 years and older. Its role as a triglyceride-lowering d...